GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Pre-Tax Income

Ind-Swift Laboratories (NSE:INDSWFTLAB) Pre-Tax Income : ₹4,876 Mil (TTM As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ind-Swift Laboratories's pretax income for the three months ended in Dec. 2024 was ₹-11 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was ₹4,876 Mil. Ind-Swift Laboratories's pretax margin was -12.48%.

During the past 13 years, Ind-Swift Laboratories's highest Pretax Margin was 109.06%. The lowest was -21.70%. And the median was 1.62%.


Ind-Swift Laboratories Pre-Tax Income Historical Data

The historical data trend for Ind-Swift Laboratories's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Pre-Tax Income Chart

Ind-Swift Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -197.71 180.09 125.32 865.21 5,817.57

Ind-Swift Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 241.94 4,871.61 9.80 5.84 -10.81

Competitive Comparison of Ind-Swift Laboratories's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift Laboratories's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's Pre-Tax Income falls into.


;
;

Ind-Swift Laboratories Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ind-Swift Laboratories's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2150.343+0+-466.938+183.714+3950.453
=5,818

Ind-Swift Laboratories's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-147.795+0+-1.14+0+138.122
=-11

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,876 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories  (NSE:INDSWFTLAB) Pre-Tax Income Explanation

Ind-Swift Laboratories's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-10.813/86.645
=-12.48%

During the past 13 years, Ind-Swift Laboratories's highest Pretax Margin was 109.06%. The lowest was -21.70%. And the median was 1.62%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ind-Swift Laboratories Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Ind-Swift Laboratories Business Description

Traded in Other Exchanges
Address
SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is engaged in the business of manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. It operates in a single segment namely, Bulk Drugs and Pharmaceuticals. Geographically, the company caters to both Indian and international markets, of which, maximum revenue is derived from outside India.

Ind-Swift Laboratories Headlines

No Headlines